Corrigendum to ‘Should IV Thrombolysis be given in Patients with Suspected Ischemic Stroke but Unknown Symptom Onset and Without Diffusion-Weighted Imaging Lesion? - Results of a Case-Control Study’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 2 (February), 2020: 104515]

The authors regret that there were two instances of inaccuracies in the published article. The name of a co-author was misspelled and should correctly be Prof. Karl Georg Haeusler. Furthermore the following must also be stated as a conflict of interest: KGH reports study grants by Bayer and Sanofi-Aventis, lecture fees / advisory board fees from Sanofi-Aventis, Pfizer, Bristol-Myers-Squibb, Boehringer Ingelheim, Daiichi Sankyo, Biotronik, WL Gore& Associates and Medtronic. The authors would like to apologise for any inconvenience caused.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Tags: Corrigendum Source Type: research